Ideagen: recurring revenues on the up

In a trading update for the half-year to October, Ideagen (IDEA) said it expects revenues and cash profits to be significantly ahead year on year – in keeping with management expectations. This momentum was driven by organic growth of 8 per cent, and the acquisitions of Medforce, InspectionXpert and MK Insight.